Posts tagged Ian Churcher
BenevolentAI hires Head of GSK Discovery Performance Unit as VP Drug discovery

Ian Churcher joins BenevolentAI as its new VP of Drug Discovery & Preclinical Development He joins BenevolentAI from GSK where he headed a Discovery Performance Unit focussed on progressing new approaches to drug discovery including pioneering development of Protein Degradation technology.

Read More